U.S. patent application number 14/312218 was filed with the patent office on 2015-03-19 for airway implants and methods and devices for insertion and retrieval.
The applicant listed for this patent is KONINKLIJKE PHILIPS N.V.. Invention is credited to Michael DINEEN, Andrew FRAZIER, Mark HIROTSUKA, Jasper JACKSON, Chad ROUE, Damien SHULOCK, Erik VAN DER BURG.
Application Number | 20150075541 14/312218 |
Document ID | / |
Family ID | 46329130 |
Filed Date | 2015-03-19 |
United States Patent
Application |
20150075541 |
Kind Code |
A1 |
DINEEN; Michael ; et
al. |
March 19, 2015 |
AIRWAY IMPLANTS AND METHODS AND DEVICES FOR INSERTION AND
RETRIEVAL
Abstract
Embodiments of the present invention relate to methods and
devices for the treatment of airway obstruction, such as
obstructive sleep apnea, and devices and methods that facilitate
insertion and retrieval of the same. In one embodiment, disclosed
is a tissue tensioner that includes an elongate flexible tether
having a first end and a second end, a bone anchor configured to be
connected to a patient's mandible, a tissue ingrowth implant
configured to be implanted in a patient's tongue and connected to
the second end of the tether, and an adjustment mechanism
configured to be held by the bone anchor adjacent the patient's
mandible and configured to receive the first end of the tether and
configured to adjust tension in the flexible tether between the
patient's mandible and tongue. Various anchors, tethers, securement
mechanisms, and adjustment mechanisms that can be used with glossal
and palatal remodeling systems are also disclosed.
Inventors: |
DINEEN; Michael; (PORTOLA
VALLEY, CA) ; HIROTSUKA; Mark; (SAN JOSE, CA)
; JACKSON; Jasper; (NEWARK, CA) ; SHULOCK;
Damien; (SAN FRANCISCO, CA) ; FRAZIER; Andrew;
(SUNNYVALE, CA) ; ROUE; Chad; (SAN JOSE, CA)
; VAN DER BURG; Erik; (LOS GATOS, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
KONINKLIJKE PHILIPS N.V. |
EINDHOVEN |
|
NL |
|
|
Family ID: |
46329130 |
Appl. No.: |
14/312218 |
Filed: |
June 23, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
13350867 |
Jan 16, 2012 |
8757163 |
|
|
14312218 |
|
|
|
|
11835931 |
Aug 8, 2007 |
8096303 |
|
|
13350867 |
|
|
|
|
11349044 |
Feb 7, 2006 |
|
|
|
11835931 |
|
|
|
|
60836579 |
Aug 8, 2006 |
|
|
|
60726028 |
Oct 12, 2005 |
|
|
|
Current U.S.
Class: |
128/848 |
Current CPC
Class: |
A61B 2017/00862
20130101; A61B 2017/0435 20130101; A61B 2017/0464 20130101; A61B
2017/0422 20130101; A61B 2017/0414 20130101; A61B 2017/00986
20130101; A61F 5/56 20130101; A61B 2017/0417 20130101; A61B
2017/044 20130101; A61B 2017/248 20130101; A61B 2017/0438 20130101;
A61B 17/0401 20130101; A61B 2017/06176 20130101; A61B 17/06166
20130101; A61B 2017/0403 20130101; A61B 2017/00814 20130101; A61B
2017/0454 20130101; A61F 5/566 20130101; A61B 2017/00004 20130101;
A61B 2017/042 20130101; A61B 17/0487 20130101; A61B 2017/0462
20130101; A61B 2017/0461 20130101; A61B 2017/06171 20130101; A61B
2017/0437 20130101; A61B 2017/0451 20130101; A61B 2017/0409
20130101; A61B 2017/0496 20130101; A61B 2017/0412 20130101; A61B
2017/0458 20130101; A61B 2017/0427 20130101; A61B 2017/0618
20130101; A61B 17/24 20130101; A61B 2017/0433 20130101 |
Class at
Publication: |
128/848 |
International
Class: |
A61F 5/56 20060101
A61F005/56 |
Claims
1. A tissue tensioner for treating a condition of a patient's
airway comprising: a flexible, elongate elastic member having a
first portion and a second portion, wherein the first portion is
configured to be secured relative to a body tissue and the second
portion is connected to a tissue ingrowth material; and a locking
bar releasably attached to the first portion and the second
portion, the locking bar configured to prevent migration of the
first portion relative to the second portion.
2. A method for treating a condition of a patient's airway, the
method comprising: positioning a tissue tensioner within a patient,
the tissue tensioner comprising a flexible, elongate elastic member
having a first portion secured relative to a body tissue and a
second portion comprising a tissue ingrowth material implanted in a
portion of the tongue, wherein a locking bar is releasably attached
to the first portion and the second portion to prevent migration of
the first portion with respect to the second portion; and manually
pulling out the locking bar to allow migration of the first portion
with respect to the second portion.
Description
[0001] The present application which claims priority under 35
U.S.C. .sctn.119(e) claims priority to U.S. patent application Ser.
No. 13/350,867, filed on Jan. 16, 2012, which claims priority under
35 U.S.C. .sctn.119(e) to U.S. patent application Ser. No.
11/835,931, filed on Aug. 8, 2007, which claims priority under 35
U.S.C. .sctn.119(e) to U.S. Provisional Application No. 60/836,579
filed on Aug. 8, 2006. The present application also claims priority
under 35 U.S.C. .sctn.120 as a continuation-in-part of U.S. patent
application Ser. No. 11/349,044, filed Feb. 7, 2006, which claims
priority to U.S. Provisional Application Nos. 60/650,867 filed Feb.
8, 2005 and 60/726,028 filed Oct. 12, 2005. All of the priority
applications are hereby incorporated by reference in their
entirety.
BACKGROUND
[0002] 1. Field of the Invention
[0003] Certain embodiments of the present invention are related to
methods and devices for the treatment of airway obstruction, such
as, for example, obstructive sleep apnea, and devices and methods
that facilitate insertion and retrieval of the same.
[0004] 2. Field of the Invention
[0005] This invention relates generally to a system and method for
treating upper airway obstruction, sleep disordered breathing,
upper airway resistance syndrome and snoring by manipulating the
structures of the oropharynx, including the tongue.
[0006] 3. Description of the Related Art
[0007] Respiratory disorders during sleep are recognized as a
common disorder with significant clinical consequences. During the
various stages of sleep, the human body exhibits different patterns
of brain and muscle activity. In particular, the REM sleep stage is
associated with reduced or irregular ventilatory responses to
chemical and mechanical stimuli and a significant degree of muscle
inhibition. This muscle inhibition may lead to relaxation of
certain muscle groups, including but not limited to muscles that
maintain the patency of the upper airways, and create a risk of
airway obstruction during sleep. Because muscle relaxation narrows
the lumen of the airway, greater inspiratory effort may be required
to overcome airway resistance. This increased inspiratory effort
paradoxically increases the degree of airway resistance and
obstruction through a Bernoulli effect on the flaccid pharyngeal
walls during REM sleep.
[0008] Obstructive Sleep Apnea (OSA) is a sleep disorder that
affects up to 2 to 4% of the population in the United States. OSA
is characterized by an intermittent cessation of airflow in the
presence of continued inspiratory effort. When these obstructive
episodes occur, an affected person will transiently arouse, regain
muscle tone and reopen the airway. Because these arousal episodes
typically occur 10 to 60 times per night, sleep fragmentation
occurs which produces excessive daytime sleepiness. Some patients
with OSA experience over 100 transient arousal episodes per
hour.
[0009] In addition to sleep disruption, OSA may also lead to
cardiovascular and pulmonary disease. Apnea episodes of 60 seconds
or more have been shown to decrease the partial pressure of oxygen
in the lung alveoli by as much as 35 to 50 mm Hg. Some studies
suggest that increased catecholamine release in the body due to the
low oxygen saturation causes increases in systemic arterial blood
pressure, which in turn causes left ventricular hypertrophy and
eventually left heart failure. OSA is also associated with
pulmonary hypertension, which can result in right heart
failure.
[0010] Radiographic studies have shown that the site of obstruction
in OSA is isolated generally to the supralaryngeal airway, but the
particular site of obstruction varies with each person and multiple
sites may be involved. A small percentage of patients with OSA have
obstructions in the nasopharynx caused by deviated septums or
enlarged turbinates. These obstructions may be treated with
septoplasty or turbinate reduction procedures, respectively. More
commonly, the oropharynx and the hypopharynx are implicated as
sites of obstruction in OSA. Some studies have reported that the
occlusion begins with the tongue falling back in an
anterior-posterior direction (A-P) to contact with the soft palate
and posterior pharyngeal wall, followed by further occlusion of the
lower pharyngeal airway in the hypopharynx. This etiology is
consistent with the physical findings associated with OSA,
including a large base of tongue, a large soft palate, shallow
palatal arch and a narrow mandibular arch. Other studies, however,
have suggested that increased compliance of the lateral walls of
the pharynx contributes to airway collapse. In the hypopharynx,
radiographic studies have reported that hypopharyngeal collapse is
frequently caused by lateral narrowing of the pharyngeal airway,
rather than narrowing in the A-P direction.
[0011] OSA is generally diagnosed by performing overnight
polysomnography in a sleep laboratory. Polysomnography typically
includes electroencephalography to measure the stages of sleep, an
electro-oculogram to measure rapid eye movements, monitoring of
respiratory effort through intercostal electromyography or
piezoelectric belts, electrocardiograms to monitor for arrhythmias,
measurement of nasal and/or oral airflow and pulse oximetry to
measure oxygen saturation of the blood.
[0012] Following the diagnosis of OSA, some patients are prescribed
weight loss programs as part of their treatment plan, because of
the association between obesity and OSA. Weight loss may reduce the
frequency of apnea in some patients, but weight loss and other
behavioral changes are difficult to achieve and maintain.
Therefore, other modalities have also been used in the treatment of
OSA, including pharmaceuticals, non-invasive devices and
surgery.
[0013] Among the pharmaceutical treatments, respiratory stimulants
and drugs that reduce REM sleep have been tried in OSA.
Progesterone, theophylline and acetozolamide have been used as
respiratory stimulants, but each drug is associated with
significant side effects and their efficacy in OSA is not well
studied. Protriptyline, a tricyclic antidepressant that reduces the
amount of REM sleep, has been shown to decrease the frequency of
apnea episodes in severe OSA, but is associated with
anti-cholinergic side effects such as impotence, dry mouth, urinary
retention and constipation.
[0014] Other modalities are directed at maintaining airway patency
during sleep. Oral appliances aimed at changing the position of the
soft palate, jaw or tongue are available, but patient discomfort
and low compliance have limited their use. Continuous Positive
Airway Pressure (CPAP) devices are often used as first-line
treatments for OSA. These devices use a sealed mask which produce
airflow at pressures of 5 to 15 cm of water and act to maintain
positive air pressure within the pharyngeal airway and thereby
maintain airway patency. Although CPAP is effective in treating
OSA, patient compliance with these devices is low for several
reasons. Sleeping with a sealed nasal mask is uncomfortable for
patients. Smaller sealed nasal masks may be more comfortable to
patients but are ineffective in patients who sleep with their
mouths open, as the air pressure will enter the nasopharynx and
then exit the oropharynx. CPAP also causes dry nasal passages and
congestion.
[0015] Surgical treatments for OSA avoid issues with patient
compliance and are useful for patients who fail conservative
treatment. One surgery used for OSA is uvulopalatopharyngoplasty
(UPPP). UPPP attempts to improve airway patency in the oropharynx
by eliminating the structures that contact the tongue during sleep.
This surgery involves removal of the uvula and a portion of the
soft palate, along with the tonsils and portions of the tonsillar
pillars. Although snoring is reduced in a majority of patients who
undergo UPPP, the percentage of patients who experience reduced
frequency of apnea episodes or improved oxygen saturation is
substantially lower. Postoperatively, many patients that have
undergone UPPP continue to exhibit oropharyngeal obstruction or
concomitant hypopharyngeal obstruction. Nonresponders often have
physical findings of a large base of tongue, an omega-shaped
epiglottis and redundant aryepiglottic folds. UPPP is not a
treatment directed at these structures. UPPP also exposes patients
to the risks of general anesthesia and postoperative swelling of
the airway that will require a tracheostomy. Excessive tissue
removal may also cause velo-pharyngeal insufficiency where food and
liquids enter into the nasopharynx during swallowing.
[0016] Laser-assisted uvulopalatopharyngoplasty (LAUP) is a similar
procedure to UPPP that uses a CO2 laser to remove the uvula and
portions of the soft palate, but the tonsils and the lateral
pharyngeal walls are not removed.
[0017] For patients who fail UPPP or LAUP, other surgical
treatments are available but these surgeries entail significantly
higher risks of morbidity and mortality. In genioglossal
advancement with hyoid myotomy (GAHM), an antero-inferior portion
of the mandible, which includes the attachment point of the tongue
musculature, is repositioned forward and in theory will pull the
tongue forward and increase airway diameter. The muscles attached
to the inferior hyoid bone are severed to allow the hyoid bone to
move superiorly and anteriorly. Repositioning of the hyoid bone
expands the retrolingual airspace by advancing the epiglottis and
tongue base anteriorly. The hyoid bone is held in its new position
by attaching to the mandible using fascia. Variants of this
procedure attach the hyoid bone inferiorly to the thyroid
cartilage.
[0018] A laser midline glossectomy (LMG) has also been tried in
some patients who have failed UPPP and who exhibit hypopharyngeal
collapse on radiographic studies. In this surgery, a laser is used
to resect the midline portion of the base of the tongue. This
involves significant morbidity and has shown only limited
effectiveness.
[0019] In some patients with craniofacial abnormalities that
include a receding mandible, mandibular or maxillomandibular
advancement surgeries may be indicated for treatment of OSA. These
patients are predisposed to OSA because the posterior mandible
position produces posterior tongue displacement that causes airway
obstruction. In a mandibular advancement procedure, the mandible is
cut bilaterally posterior to the last molar and advanced forward
approximately 10 to 14 mm. Bone grafts are used to bridge the bone
gap and the newly positioned mandible is wire fixated to the
maxilla until healing occurs. Mandibular advancement may be
combined with a Le Fort I maxillary osteotomy procedure to correct
associated dental or facial abnormalities. These procedures have a
high morbidity and are indicated only in refractory cases of
OSA.
[0020] Experimental procedures described in the clinical literature
for OSA include the volumetric radiofrequency tissue ablation and
hyoidplasty, where the hyoid bone is cut into several segments and
attached to a brace that widens the angle of the U-shaped hyoid
bone. The latter procedure has been used in dogs to increase the
pharyngeal airway lumen at the level of the hyoid bone. The canine
hyoid bone, however, is unlike a human hyoid bone because the
canine hyoid bone comprises nine separate and jointed bones, while
the human hyoid bone comprises five bones that are typically fused
together.
[0021] Notwithstanding the foregoing, there remains a need for
improved methods and devices for treating obstructive sleep
apnea.
SUMMARY OF THE INVENTION
[0022] Methods and devices for manipulating tissue are provided. A
tissue-tensioner is used to tension a region of tissue. The tissue
tensioner is used to engage certain tissue of the body and apply
tension to those tissues.
[0023] In further embodiments, methods and devices are disclosed
for manipulating the tongue, or alternatively the soft palate. A
tissue engaging structure can be positioned on the tongue, and the
device is manipulated to displace at least a portion of the
posterior tongue in an anterior or lateral direction, or to alter
the tissue tension or compliance of the tongue.
[0024] In one embodiment, disclosed is a tissue tensioner for
treating a condition of a patient's airway, said tissue tensioner
including an elongate flexible tether having a first end and a
second end; a bone anchor configured to be connected to a patient's
mandible; and a tissue ingrowth implant configured to be implanted
in a patient's tongue. The tissue ingrowth implant can be connected
to the second end of the tether. The tissue tensioner can also
include an adjustment mechanism configured to be held by the bone
anchor adjacent the patient's mandible. The adjustment mechanism
can be configured to receive the first end of the tether, as well
as configured to adjust tension in the flexible tether between the
patient's mandible and the patient's tongue. In some embodiments
the elongate member can include either an active variable length
tether or a coating tending to cause tissue ingrowth. The
adjustment mechanism can include a rotational assembly such as a
spool.
[0025] In one embodiment, disclosed is a tissue tensioner for
treating a condition of a patient's airway, the tensioner including
an elongate flexible tension member; a first portion of the tension
member configured to be secured relative to a body tissue; and a
second portion of the tension member including a tissue ingrowth
material configured to be secured to a portion of a tongue; and an
adjustment mechanism configured to adjust tension in the tension
member between the body tissue and said portion of the tongue. In
some embodiments the first portion of the tension member can be
connected to either a bone anchor or a tissue anchor. In some
embodiments the tissue ingrowth material is a single strand of
woven material which may be partially covered by a cap element. The
cap element can be radiopaque. The tension member can be beaded in
some embodiments.
[0026] In one embodiment, a method for treating airway obstruction
is disclosed. The method includes the steps of placing a tissue
tensioner within a patient's tongue, the tensioner including a
flexible elongate tension member having a first portion configured
to be secured relative to a body tissue and a second portion that
is connected to a tissue ingrowth material; an adjustment mechanism
configured to adjust tension in the tension member between the body
tissue and the tissue ingrowth material; securing the first portion
relative to a body tissue and implanting the tissue ingrowth
material within a portion of the tongue; and adjusting the tension
of the tension member by manipulating the adjustment mechanism. In
some embodiments the first portion is either secured relative to a
patient's mandible using a bone anchor, or secured to tongue tissue
using a tissue anchor. In some embodiments, the tissue ingrowth
implant includes a single strand of woven material.
[0027] In another embodiment, disclosed is a tissue tensioner for
treating a condition of a patient's airway, including an elongate
flexible tension member comprising a first portion and a second
portion; the first portion of the tension member being securable
relative to a body tissue; the second portion being connected to a
tissue ingrowth material; and means for adjusting the tension
between the tissue ingrowth material and the body tissue. In some
embodiments, the first portion of the tension member can be
configured to be connected to either a bone anchor or a tissue
anchor.
[0028] In another embodiment, disclosed is a tissue tensioner for
treating a condition of a patient's airway that includes a flexible
elongate tension member having a first portion and a second
portion. The first portion can be securable relative to a body
tissue, and the second portion can be connected to an implant
including a single woven strand and configured to be implanted in a
patient's tongue. A cap element can cover a portion of the woven
implant.
[0029] In one embodiment, disclosed is a method for treating airway
obstruction including the steps of deploying a tissue tensioner
into a patient's tongue, the tissue tensioner including a flexible
elongate tension member having a first portion secured relative to
a body tissue and a second portion including a single strand woven
implant that can be implanted in a patient's tongue. In some
embodiments, the method also includes the step of removing the
tissue tensioner from the patient by pulling on the single strand
with sufficient force such that the woven implant unravels. The
first portion may be secured either relative to the patient's
mandible or within the patient's tongue.
[0030] In one embodiment, disclosed is a tissue tensioner for
treating a condition of a patient's airway including a flexible
elongate elastic member having a first portion and a second
portion, wherein the first portion is configured to be secured
relative to a body tissue and the second portion is connected to a
tissue ingrowth material; and a locking bar releasably attached to
the first portion and the second portion. The locking bar can be
configured to prevent migration of the first portion relative to
the second portion.
[0031] In one embodiment, disclosed is a method for treating a
condition of a patient's airway, the method including the step of
positioning a tissue tensioner within a patient. The tissue
tensioner can include a flexible, elongate elastic member having a
first portion secured relative to a body tissue and a second
portion comprising a tissue ingrowth material implanted in a
portion of the tongue. A locking bar is preferably releasably
attached to the first portion and the second portion to prevent
migration of the first portion with respect to the second portion.
The locking bar can be manually pulled out to allow migration of
the first portion with respect to the second portion.
[0032] In yet another embodiment, disclosed is a method for
removing a tissue tensioner including the steps of providing a
tissue tensioner, the tissue tensioner comprising a batten implant
connected to a flexible tether; threading the flexible tether
through a dilator; advancing the dilator over the flexible tether
through tissue to the batten implant; advancing a cannula over
dilator and over the implant; and removing the batten implant, the
cannula, and the dilator. In some embodiments, at least a portion
of the tissue ingrowth material is covered by a cap element.
[0033] In one embodiment, disclosed is a method for treating a
condition of a patient's airway, including the steps of passing a
first tension member through a patient's genioglossus muscle
exiting the dorsum lateral to a midline of the patient's tongue
creating a first exit hole; passing a second tension member through
the patient's genioglossus muscle exiting the dorsum lateral to the
midline of the patient's tongue creating a second exit hole;
passing a sling element under the tongue surface though the first
exit hole and the second exit hole; attaching the first tension
member to a first portion of the sling; attaching the second
tension member to a second portion of the sling; and securing first
and second tension members relative to body tissue. In some
embodiments the first and second tension members are secured to
bone anchors.
[0034] In another embodiment, disclosed is a method for treating
airway obstruction including the steps of placing a tissue
tensioner within a patient's oral cavity, the tensioner including a
flexible elongate tension member having a first portion configured
to be secured relative to a body tissue and a second portion that
is connected to a tissue ingrowth material; an adjustment mechanism
configured to adjust tension in the tension member between the body
tissue and the tissue ingrowth material; securing the first portion
relative to a body tissue and implanting the tissue ingrowth
material within a portion of the patient's soft palate; and
adjusting the tension of the tension member by manipulating the
adjustment mechanism. In some embodiments the first portion is
secured relative to a patient's hard palate.
[0035] In still another embodiment, disclosed is a tissue tensioner
for treating a condition of an airway, the tissue tensioner
including: an elongate flexible tension member, a first portion of
the tension member connected to a first tissue ingrowth material
and a second portion of the tension member connected to a second
tissue ingrowth material; and an adjustment mechanism configured to
adjust tension in the tension member between the first tissue
ingrowth material and the second tissue ingrowth material. In some
embodiments the first tissue ingrowth material is implanted in a
first body tissue and the second tissue ingrowth material is
implanted in a second body tissue.
[0036] In yet another embodiment, disclosed is a method for
treating airway obstruction, the method including placing a tissue
tensioner within the tongue, the tensioner including a flexible
elongate tension member having a first portion connected to a first
tissue ingrowth material and a second portion connected to a second
tissue ingrowth material; implanting the first tissue ingrowth
material in a first portion of the tongue and implanting the second
tissue ingrowth material in a second portion of the tongue; and
adjusting the tension or length of the tension member by
manipulating an adjustment mechanism configured to adjust tension
in the tension member between the first tissue ingrowth material
and the second tissue ingrowth material.
[0037] In another embodiment, disclosed is a tissue tensioner for
treating a condition of a patient's airway, the tissue tensioner
including an elongate flexible tension member, a first portion of
the tension member including a tissue anchor configured to be
secured to a first portion of a patient's tongue and a second
portion of the tension member including a tissue ingrowth material
configured to be secured to a second portion of the patient's
tongue. The tissue anchor may include a fishbone anchor that has a
plurality of barbs extending radially from the tension member.
[0038] In another embodiment, disclosed is a method for treating
airway obstruction including placing a tissue implant within a
patient's tongue or palate, the tissue implant comprising a
multiple-pronged stiffening element; and expanding the stiffening
element within the tongue or palate to stretch tissue laterally.
The stiffening implant may have at least one, two, three, four,
five, or more prongs.
BRIEF DESCRIPTION OF THE DRAWINGS
[0039] FIG. 1 illustrates tongue and soft palate implants including
adjustment elements to adjust the tension of a tether, according to
one embodiment of the invention.
[0040] FIG. 2 is a schematic diagram showing one example of a
securement assembly that may be used with a tongue or hyoid
suspension system, according to one embodiment of the
invention.
[0041] FIG. 3 shows tongue and soft palate implants comprising
tethers with a beaded shape, according to one embodiment of the
invention.
[0042] FIGS. 4A-C depict a tongue suspension system comprising a
multi-piece sling, according to one embodiment of the
invention.
[0043] FIG. 5 shows a tongue suspension system with an elongated
member comprising a double-ended anchor, according to one
embodiment of the invention.
[0044] FIGS. 6A-B illustrate an anchor with a plurality of barbs
that may be self-expandable, according to one embodiment of the
invention.
[0045] FIGS. 7A-B show an implant comprising a multi-pronged
stiffening element, according to one embodiment of the
invention.
[0046] FIGS. 8A-B illustrate a woven tissue implant that can be
conveniently removed after implantation, according to one
embodiment of the invention.
[0047] FIGS. 9A-C show a tissue implant that comprises a locking
rod, according to one embodiment of the invention.
[0048] FIGS. 10A-C illustrate a recapture/removal tool for a
batten-style implant, according to one embodiment of the
invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0049] Causes of airway obstruction include but are not limited to
obstructive sleep apnea, snoring and congenital disorders such as
Pierre-Robin syndrome. Disclosed herein are various embodiments of
devices or implants and methods for treating causes of airway
obstruction. Embodiments described herein relate to, for example,
adjustability, tethers, and anchors of those implants to treat said
conditions. Also disclosed herein are methods and devices for
deployment and retrieval of the implants disclosed. Some of such
devices and methods are further described in co-pending application
Ser. No. 11/349,040, filed Feb. 7, 2006, as well as in U.S. Patent
Publication Nos. 2005/0092332 and 2005/0092334 to Conrad et al.
(herein, "Conrad"), which are hereby incorporated by reference in
their entirety. References to figures disclosed in Conrad herein
refer to Publication No. 2005/0092334. In various embodiments,
Conrad discloses implants and methods of using the implants to
alter the geometry and position of the tongue and soft palate.
Embodiments disclosed herein may also be adapted for use with the
PILLAR.RTM. system of Restore Medical (St. Paul, Minn.).
[0050] U.S. patent application Ser. No. 11/349,040, filed Feb. 7,
2006 and published Sep. 14, 2006 as U.S. Patent Pub. No.
2006-0201519 A1 ("Frazier '519 publication"); U.S. Provisional
Patent Application No. 60/813,230, filed Jun. 13, 2006 ("'230
provisional application"); U.S. Provisional Patent Application No.
60/813,285, filed Jun. 13, 2006 ("'285 provisional application);
U.S. Patent Application No. 60/813,058, filed Jun. 13, 2006 ("'058
provisional application"); U.S. Patent Publication No. 2005/0092334
to Conrad et al ("Conrad"); U.S. Pat. No. 6,250,307 to Conrad et
al. ("Conrad '307"); U.S. patent application Ser. No. 11/762,642
filed Jun. 13, 2007 ("Dineen '642 application"); U.S. patent
application Ser. No. 11/762,752 filed Jun. 13, 2007 ("`Hirotsuka
'752 application"); and U.S. patent application Ser. No. 11/762,652
filed Jun. 13, 2007 ("Jackson '652 application") are all
incorporated by reference herein in their entirety.
[0051] Conrad discloses various methods and apparatuses for
treating a condition of a patient's airway. FIG. 1 of Conrad
illustrates an implant 10 that may be completely implanted within
the tongue T, or alternatively, the soft palate SP. The implant 10
comprises an elongated member 12 having a tissue in-growth end 14
and a static end 16. In some embodiments, as shown in FIG. 3 of
Conrad, the elongated member 12a may be resilient, e.g., in the
form of a spring member which may be stretched to create a bias
urging tissue in-growth 14a and static ends 16a of the spring
together. In some embodiments, the implant may comprise a
bioresorbable material 20 positioned between the tissue-engaging
end 14a of the elongated member 12a and an anchor 18a. The tissue
in-growth end 14a may be a tissue growth inducing material (e.g.,
felt or PET) to induce growth of tissue into the end to secure the
end to surrounding tissue following implantation. An anchor 18a,
positioned proximally (e.g., a threaded eye-bolt) is secured to the
mandible JB for tongue implants, and the hard palate HP for soft
palate SP implants 10'. The static end 16 of the elongated member
12 is secured to the anchor 18. The tissue in-growth end 14 is
placed in the tongue T near the tongue base TB. A surgeon adjusts
the tension of the suture 12, causing the tongue base TB to be
advanced toward the mandible JB thereby placing the tissue of the
tongue T in compression. The surgeon may tie off the static end 16
at the anchor 18 retaining the tissue of the tongue T under
tension. Other anatomical structures shown include the trachea TR,
epiglottis EP, esophagus ES, pharyngeal wall PW, trailing end of
the soft palate TE, mouth M, and nasal cavity N.
[0052] In some embodiments, as shown in FIG. 11 of Conrad, tissue
in-growth material 118 deployed proximally acts as an embedded
anchor and eliminates the need for placement of an anchor in the
mandible JB.
Adjustment Mechanisms
[0053] As noted above, FIG. 1 of Conrad illustrates an implant 10
that includes an elongated member 12 (also referred herein as a
tether or a tension member) having a tissue in-growth end 14 and a
static end 16. In some embodiments, as shown in FIG. 3 of Conrad,
the elongated member may be resilient, e.g., in the form of a
spring member 12a which may be stretched to create a bias urging
tissue in-growth 14a and static ends 16a of the spring 12a
together. In some embodiments, the implant 10a may comprise a
bioresorbable material 20 positioned between the tissue-engaging
end 14a of the elongated member 12a and an anchor 18a. The tissue
in-growth end 14a may be a tissue growth inducing material (e.g.,
felt or PET) to induce growth of tissue into the end to secure the
end to surrounding tissue following implantation.
[0054] In some embodiments, the devices discussed above can also
include one or more adjustment elements, for example, one or more
adjustment elements selected from those described in the Frazier
'519 publication (e.g., those illustrated in FIGS. 61A-K of the
Frazier '519 publication), the '230 provisional application (e.g.,
those illustrated in FIGS. 73-108 of the '230 provisional
application), or the Dineen '642 application (e.g., those
illustrated in FIGS. 73-98 of the Dineen '642 application).
Adjustment elements can advantageously allow for adjusting the
tension of the elongated member disclosed in Conrad after
implantation of the tongue or palatal suspension system. A tongue
or palatal remodeling system, device, and/or method for treating a
patient with breathing problems that can be adjusted either before,
during and/or after the initial implantation procedure may be
better tolerated and less prone to treatment failure. For example,
by being able to adjust the tension or bias of the elongated member
disclosed in Conrad by methods other than by cutting and re-tying
the elongated member at times other than during implantation,
migration, extrusion, and/or dysphagia may be avoided or
corrected.
[0055] For example, in one embodiment of the invention, shown
schematically in FIG. 1 herein, the improved tongue suspension
system 5020 includes one or more spools or rotation assemblies
5020, such as a spool assembly illustrated in FIGS. 61A to 61I of
the Frazier '519 publication, for adjusting the tension of an
elongated member 5012 between the mandibular anchor 5018 (attached
to static end 5016 of the system) and the tissue in-growth end 5014
of the elongated member 5012, such as one disclosed in Conrad. A
improved palatal suspension system 5030 is also shown in FIG. 1
that can be similar to the tongue suspension system, including one
or more spools or rotation assemblies 5020' for adjusting the
tension of an elongated member 5012' between a bone or hard palate
anchor 5018' (attached to static end 5016' of the system) and the
tissue in-growth end 5014 of the elongated member 5102' attached to
the soft palate. In some embodiments, the elongated member may be
configured to adjust the tension between a soft tissue anchor and
the tissue ingrowth end.
Securement Assemblies
[0056] In some embodiments, the aforementioned implants may include
one or more securement mechanisms selected from those disclosed in
disclosed in the Frazier '519 publication, (e.g., securement
mechanisms illustrated in FIGS. 40-51 of the Frazier '519
publication) which may be configured for use a system such as the
one disclosed in Conrad. For example, the bone anchor disclosed in
Conrad may be replaced by a securement mechanism as disclosed in
the Frazier '519 publication. The securement mechanism may be
configured to hold the elongated member disclosed in Conrad or one
or more tethers disclosed in, for example, the Frazier '519
publication or the Hirotsuka '752 application.
[0057] In one embodiment, illustrated schematically in FIG. 2, the
tongue or soft palate implant such as one disclosed in Conrad
includes a bone anchor 186 with a clamping interface 188 for
retaining tethers 28, as illustrated in connection with FIGS. 40A-C
of the Frazier '519 publication. The clamping interface 188
comprises two opposing surfaces 190, 192 or structures that are
adapted to provide a frictional or mechanical interface with
tethers 28 or other elongate members inserted within the clamping
interface 188. The clamping interface 188 has an open configuration
depicted in FIGS. 40A-C of the Frazier '519 publication to allow
positioning of one or more tethers 28 within the interface 188 and
a closed configuration shown for retaining the tethers 28. The
closed configuration may be achieved by crimping the two opposing
surfaces 190, 192 or by further structures of the clamping
interface, such as complementary clasps or clip structures to fix
the opposing surfaces 190, 192 together. As shown in FIG. 40C of
the Frazier '519 publication, the clamping interface 188 may
further comprise complementary indentations 194 and protrusions 196
to further enhance the frictional resistance of the interface in
the closed configuration. The opposing surfaces or structures of
the clamping interface may also be configured with frictional
surfaces that are well known in the art through the use of various
materials, surface treatments or configurations. Frictional surface
configurations may also include cross hatched surfaces or irregular
porous surfaces.
Tethers
[0058] As described above, Conrad teaches an elongated member
having a tissue in-growth end and a static end. In some
embodiments, as shown in FIG. 3 of Conrad, the elongated member 12a
may be resilient, e.g., in the form of a spring member 12a which
may be stretched to create a bias urging tissue in-growth 14a and
static 16a ends of the spring together. An elongated member, such
as one disclosed in Conrad may include any one of various tethers
disclosed in the Frazier '519 publication (e.g., those illustrated
in FIGS. 27-38 of the Frazier '519 publication), the '285
provisional application (e.g., those illustrated in FIGS. 73-84 of
the '285 provisional application), or the Hirotsuka '752
application (e.g., those illustrated in FIGS. 73-80C of the
Hirotsuka '752 application), and configured for use with the
aforementioned Conrad tongue or palatal implants. A tether with
elastic properties or comprising structures that provide a
length/tension relationship may be preferred in some instances. A
tether capable of lengthening in response to increased load or
tension may be optimized to provide sufficient bias to reduce the
effects of oropharyngeal occlusion while providing a more
physiologic range of tongue or soft palate motion than that
produced by fixed length tethers. Fixed length glossoplasty or
suspension of the tongue may be the cause of odynophagia, dysphagia
and deglutition problems seen with existing tongue remodeling
devices, but the current invention is not limited to this purpose.
A tether with elastomeric properties may be provided by using
materials such as but not limited to urethane or silicone. One
skilled in the art can select the particular material, tether
length, diameter, cross-sectional shape and other features based
upon the desired effect, tolerances, and the particular patient's
anatomical characteristics. Other materials that may comprise the
tether include but are not limited to Nitinol, spring steel,
tantalum, polyethylene, polyester, silk, polypropylene, polyolefin
or a combination thereof.
[0059] Other tether configurations that may be used include passive
and active variable length or bias structures such as braided or
woven structures, electropolymers, springs, coils, magnets or
solenoids. Thus, in some of the embodiments, the tether
configuration may actively change in length or configuration
resulting from the application of external energy or force such as
electrical current or magnets. These active tether configurations
may be further configured with local or distal sensor components
that may modulate the activity of the external energy or force
acting on the active tether. The modulation may be influenced or
triggered by detection of diaphragm movement or depolarization
activity, nerve depolarization, pressure changes and/mechanical
contact in the airway.
[0060] The tether may also be covered by a lubricious biocompatible
coating. In another embodiment, the tether comprises a
bioabsorbable coating that may cause scar or connective tissue
formation about the tether. Scar tissue formation may further
enhance the effect of the glossoplasty implant by tightening the
tongue tissue (or similarly with regard to a palatal implant)
and/or to resist migration of the implant.
[0061] In some embodiments, a tether of a tissue engaging member
may be configured with one or more structures or surfaces capable
of engaging at least a portion of the tissue surrounding the tether
so that an anchor is not required, or to distribute the tissue
engagement. In still other embodiments, the tissue engaging member
may comprise multiple anchors and multiple tethers arranged in a
serial or branching fashion.
[0062] FIG. 3 illustrates an embodiment of tongue 5050 and soft
tissue 5050' implants, both comprising a beaded tether 5040, 5040',
as disclosed in, for example, the Frazier '519 publication, the
'285 provisional application, and the Hirotsuka '752 application.
The beaded tether 5040, 5040' may advantageously promote tissue
in-growth and better tension the tongue 5050 or soft palate 5050'
suspension system. In other embodiments, one or more tethers
selected from the tethers disclosed in the Frazier '519
publication, the '285 provisional application, or the Hirotsuka
'752 application replace the elongated member disclosed in
Conrad.
[0063] As illustrated in FIGS. 4A-4C, in one embodiment, an
improved tongue suspension system 5060 comprises a tether further
comprising one or more "sling" elements 5062 on a tongue or
palate-based implant system such as disclosed in Conrad. The sling
element 5062 may comprise, for example, a batten of porous fabric,
woven material, a large diameter suture, braid, band, and the like.
The sling element 5062 may be operably connected to, or replace the
elongated member disclosed in Conrad. In some embodiments, the
sling element 5062 comprises a central lumen configured to receive
one or more sutures within the lumen. The sling element 5062 may
alleviate trauma during installation of the tongue suspension
system 5060 because the enlarged suture portion 5062 need not be
passed through the entire tongue T. The sling 5062 can also
advantageously increase anchoring surface area in the tongue T and
prevent undesired migration of the elongated member.
[0064] A method of deploying an improved tongue suspension system
5060 comprising a sling element 5062 is disclosed herein, and
illustrated in FIGS. 4A-4C. The method comprises the step of
passing a first elongated member 5064 through the genioglossus
muscle 5100 exiting the dorsum lateral to the midline. Next, a
second elongated member 5066 is passed through the genioglossus
muscle 5100 exiting the dorsum lateral to the midline on the
contralateral side. Next, a sling element 5062 is passed under the
tongue T surface between exit holes created from the passing of the
first 5064 and second 5066 elongated members through the
genioglossus muscle 5100. Then, elongated members 5064, 5066, such
as sutures are attached to each end of the sling element 5062. In
some embodiments with a sling element 5062 that further include a
lumen, the portion of the elongated member within the sling element
may be secured within the lumen of the sling element 5062. The
elongated members 5064, 5066 outside of the sling element may then
be attached to the bone anchor 5068. In another embodiment, the
sling element 5062 is formed during the procedure by passing a
plurality of sutures transversely through the tongue along
different pathways. The ends of the sutures located to each side of
the midline tongue are then joined together to form the ends of the
sling element. The in situ formed sling element can then be
attached to the first and second sutures as described above.
Tissue Engagement
[0065] As described above, Conrad teaches an elongated member
having a tissue in-growth end. In some embodiments, as described
with reference to FIG. 11 Of Conrad, the elongated member 12 has
two tissue in-growth ends (e.g., felt or PET); a proximal in-growth
end 118 acting as an embedded anchor eliminating the need for
placing an anchor in the mandible, and a distal in-growth end 14
for tensioning the tongue suspension system. In one embodiment of
the present invention, a tongue suspension system comprises an
implant with one or more anchors selected from the anchors
disclosed in the Frazier '519 publication (e.g., as illustrated in
FIGS. 7-26 of the Frazier '519 publication), the '058 provisional
application (e.g., as illustrated in FIGS. 73-112 of the '058
provisional application), or the Jackson '652 application replacing
the one or more tissue in-growth ends of a tongue or palatal
implant disclosed in Conrad. The anchors can advantageously improve
tongue or palatal suspension by providing a greater surface area
and resistance to migration of the implant. For example, in one
embodiment as illustrated schematically in FIG. 5 herein, the
tissue in-growth ends may comprise double-ended anchors 5080 as
illustrated, for example, in FIGS. 86-112 of the '058 provisional
application, or the anchors of the Jackson '652 application. The
anchor may be operably connected to the elongated member as
disclosed in Conrad, or a tether as disclosed in the Frazier '519
application, '058 provisional application, or the Jackson '652
application as noted above. Other tissue ingrowth materials that
may be used include polypropylene, polytetrafluoroethylenes,
polyurethanes, polyesters, ceramics, porous metals or combinations
thereof. In some embodiments, bioglues may be used to facilitate
tissue adhesion to the implant. Bioglues may be injected at the
implantation site or provided as a coating on the implant. A
bioglue coating may provided at the point of manufacture or the
point of service. In some embodiments, a tongue suspension system
may include a first tissue ingrowth portion and a second tissue
ingrowth portion, connected by a flexible elongate tether. The
length and/or tension of the tether can be adjusted using an
adjustment mechanism described herein, for example, a spool.
[0066] In some embodiments as shown in FIG. 5, soft palate
implants, such as those disclosed in Conrad may include one or more
anchors 5082' selected from those disclosed in the Frazier '519
publication (e.g., FIGS. 63-69 of the Frazier '519 publication)
replacing the one or more tissue ingrowth ends of the expandable
member, for example, as illustrated in Conrad FIGS. 1-2.
[0067] Another embodiment of an improved tongue or palatal
suspension system comprises one or more tissue-engaging anchors
5090 as illustrated schematically in FIGS. 6A-B herein. The anchor
5090 may be deployed distally, proximally, or both distally and
proximally (relative to the position of the tongue or the palate),
and connected by a tether that is preferably elongate and flexible
in some embodiments. The anchor 5090 may optionally comprise a
plurality of "fish bone" shaped barbs 5092 in series extending
radially out from and operably connected at one end to the anchor
5090 as illustrated. The angles of the barbs 5092 when fully
deployed may range anywhere from about 0 degrees to about 180
degrees with respect to vector of insertion, preferably about 45
degrees to 135 degrees, and most preferably about 60 degrees to
about 150 degrees. The angles of the barbs 5092 may be uniform or
non-uniform along the length of the implant 5090. Although the
barbs 5092 in FIGS. 6A-B are arranged in pairs within a common
plane of orientation, in other embodiments the barbs 5092 may be
unpaired and/or circumferentially arranged. The barbs 5092 may be
made of Nitinol, other metals, one or more polymers, or other
suitable material. In some embodiments, the barbs 5092 may be
bioabsorbable to decrease tissue irritation as well as to
facilitate tissue ingrowth. In some embodiments, at least 1, 2, 3,
4, 5, 6, 7, 8, 9, 10, or more barbs may be present. The anchor 5090
may be predeployed in a first, collapsed configuration, as
schematically illustrated in FIG. 6A within a delivery tube (not
shown). Upon removal of the delivery tube, for example, within the
genioglossus muscle, the barbs 5092 spring outward to engage the
tissue, as shown in FIG. 6B. The anchor 5090 may be attached to an
adjustable securement assembly as described above and disclosed in
the Frazier '519 publication. The adjustability is especially
advantageous when the anchor 5090 is placed untensioned, and
tensioned at a later time after a healing and tissue ingrowth
period. The anchor 5090 disclosed herein may also be configured for
use for soft palate implants as disclosed in Conrad, as well as
Conrad '307.
[0068] Conrad discloses several implants to stiffen the base of the
tongue and resist floppy action or lack of tone in the tissue of
the tongue near the base. For example, FIG. 8 of Conrad illustrates
contracting implants 40 that may be placed in the tongue T in-line
with radiating lines A of certain muscles of the tongue (e.g.,
genioglossus muscles). As the implants 40 contract over time, they
urge the tongue T from collapsing toward the pharyngeal wall PW.
FIG. 12-13 of Conrad illustrates implants 120 spaced apart for
fibrosis to interconnect between the implants 120. FIGS. 14-17 of
Conrad illustrate the use of embedded crimps or staples 150 to
stiffen and potentially illustrate the tongue base. In the
embodiments shown in FIGS. 14-15, the crimps 150 are slightly
curved members which are placed in the tongue with concave surfaces
opposing the tongue base. The crimping acts to squeeze tissue of
the tongue to stiffen the tongue.
[0069] In another embodiment, of the invention, disclosed is a
multi-pronged stiffening element 5100, schematically illustrated
implanted in a soft palate herein in FIGS. 7A-B. The stiffening
element 5100 may have at least about two, three, four, five or more
prongs and be implanted, for example, in the tongue, palate, and
the like. The stiffening element 5100 increases stiffness within
the implanted tissue by stretching the tissue in one or more
directions. In some embodiments, the tissue is stretched laterally.
In some embodiments, the stiffening element 5100 is trident-shaped
as shown. However, one of ordinary skill in the art will appreciate
that many other possible shapes are possible. The stiffening
element may be expandable after delivery.
Recapturability
[0070] FIGS. 8A-B illustrate an embodiment of an improved woven
tissue implant 5104 that can advantageously be easily removed,
from, e.g., the tongue or the soft palate. The implant 5104 may be
a batten type stiffener or tissue anchor formed from a single
strand. The single strand can be woven or knitted into a desired
shape, for example, a rod-like structure. The woven tissue implant
5104 may be deployed into tissue to stiffen a particular area and
serve a similar function to the implants illustrated in FIGS. 8 and
12-17 of Conrad or implants of the PILLAR.RTM. system (Restore
Medical), or attached to one or more tethers for use as a tissue
anchor or sling. The woven design facilitates tissue ingrowth
within the spaces around the woven implant 5014, effectively
increasing the surface area of the implant 5104 and increasing the
implant's anchoring force. The implant 5104 is most preferably
configured to have sufficient structural integrity necessary to
anchor tissue. However, the woven implant 5104 is also preferably
configured such that pulling on an end of the single strand of the
implant with an appropriate force will unwind or unravel the
implant 5104 into a long filament (as shown in FIG. 8B) for simple
and convenient removal of the implant. The appropriate force
required to unwind the implant 5104 is most preferably sufficiently
greater than the tensioning force of the tissue on the implant 5104
while deployed in the tongue, palate, or surrounding tissue so that
the implant 5104 does not undesirably unwind while deployed. Part
or all of the implant 5104 may include a radiopaque marker
material.
[0071] As illustrated in FIG. 3 of Conrad, the implant may comprise
a bioresorbable material 20 positioned between the tissue-engaging
end 14a of the elongated member 12a and an anchor 16a. The
bioresorbable material 20 may oppose a spring member 12a which may
be stretched to create a bias urging ends 14a, 16a of the elongated
member 12a toward one another. The bioresorbable material 20
positioned between the tissue-engaging end 14a and a bolt 18a will
later resorb into the tissue of the tongue T permitting the end to
be urged toward the bolt 18a by the resilience of the spring 12a,
tensioning the device.
[0072] FIG. 9 herein illustrates an improved embodiment of a tether
5108 that may be used with tissue ingrowth implants, such as, for
example, those disclosed in Conrad. An improved tether 5108
comprises a locking bar 5112 releasably attached to both the tissue
ingrowth end 5014 and the bone anchor 5018 (or both tissue ingrowth
ends in some embodiments) and disposed within an elastic member
5110. The elastic member 5110 is preferably connected to an implant
or anchor 5014 (such as the tissue ingrowth engaging member of
Conrad) at a first end and a securing element 5018 (such as a bone
anchor) or another tissue anchor at a second end. The locking bar
5112 may comprise one or more forked or capped ends 5113. The
locking bar 5112 may comprise metal, polymer, or other
biocompatible material, but preferably has a relatively low
elasticity to prevent migration of the implant or anchor 5014 in
the acute post-implantation period. During this period, there may
be inadequate tissue ingrowth for the implant or anchor 5014 to
provide a sufficient anchoring force to tension the tether 5110.
Other tethers that can also be used to provide a temporary or
permanent anchoring force are disclosed in, for example, the
Frazier '519 publication, the '285 provisional application, and the
Hirotsuka '752 application.
[0073] The locking bar 5112 provides the appropriate anchoring
force until adequate tissue ingrowth occurs and the elastic member
5110 can be appropriately tensioned (as an alternative, for
example, to the bioresorbable material solution illustrated in FIG.
3 of Conrad). When adequate tissue ingrowth occurs, the locking bar
5112 may be removed via a recapture tool as disclosed elsewhere in
the application and the Frazier '519 publication (e.g., at FIGS.
70-72 of the Frazier '519 publication). The locking bar 5112 can be
accessed via a surgical procedure and pulled out manually. In other
embodiments, the locking bar 5112 may comprise a tether line
running to the bone anchor 5018 which can be used with a
percutaneous recapture system, such as the system disclosed in the
Frazier '519 publication, for removal. A dilator tool can follow
the tether to an end of the locking bar 5112, and the locking bar
5112 could then be pulled out. If the locking bar 5112 is made from
a smooth material (e.g., a metal or plastic rod) the tether line
can be pulled directly to remove the bar without the need for a
dilator tool. In some embodiments, the locking bar 5112 may be made
of a biodegradable material, such as polylactic acid, polyglycolic
acid and the like, that degrades at a rate slow enough to continue
to provide anchoring force to the implant 5014 until adequate
tissue ingrowth allows the elastic member 5110 to be appropriately
tensioned.
[0074] Various devices and methods to promote recapturability and
removal of a batten implant, such as, for example, implants
illustrated in FIGS. 8 and 12-17 of Conrad, implants disclosed in
U.S. Pat. No. 6,250,307 to Conrad et al., and the PILLAR.RTM.
System (Restore Medical) are disclosed. An improved batten-style
implant 5120, illustrated in FIGS. 10A-C herein, comprises one or
more cap elements 5122. The cap elements 5122 are preferably
attached to the proximal end, distal end, or both ends of the
batten implant. In some embodiments, the cap element 5122 covers a
substantial portion, or even the entire batten implant 5120. The
cap element 5122 may be made of, for example, plastic, metal,
Dacron, ePTFE, and the like. In some embodiments, the cap element
5122 comprises radiopaque material such that the cap 5122 can be
visualized on plain film radiographs. In other embodiments, the cap
element 5122 comprises material that can be visualized on
ultrasound, magnetic resonance imaging, or other imaging
modalities.
[0075] The cap elements 5122 can advantageously assist in guiding
an implant removal device, such as a cannula 5124, onto the main
body of the implant 5120 such that the cutting edges of the removal
device 5124 can separate the fibrous encapsulation near the implant
surface without cutting into, or otherwise damaging the implant
body 5120. The cap elements 5122 may be especially advantageous
when the implant 5120 is tethered, for example, when the implant
5120 is used as a tissue anchor to apply traction to the tongue or
the palate. Thus, the cap elements 5122 may allow the batten
implant 5120 to readily and safely removed from tissue while
minimizing tissue trauma and reducing the risk of damage to the
implant 5120 complicating removal through increased force or
cutting or tearing of the implant 5120.
[0076] A method for recapturing a batten implant 5120 will be
described. First, trailing sutures 5012 are threaded through a
dilator with a cannula assembly 5124, such as a recapture tool
depicted in FIGS. 7G to 7J and FIGS. 70-72 of the Frazier '519
publication. Next, the cannula and dilator 5124 (shown
schematically as a single cannula for simplicity in FIGS. 10B-C)
are advanced over the sutures 5012 and through tissue to the batten
implant 5120. In batten implant 5120 embodiments that comprise an
imaging marker, the cannula and dilator 5124 may be guided by, for
example, an appropriate technique to detect the imaging marker,
such as fluoroscopy, ultrasound, CT, MRI, and the like. Fibrous
tissue may be dissected from the sutures 5012 using the dilator
5124. Then, in embodiments of implants 5120 that comprise one or
more cap elements 5122, the cannula 5124 is advanced over the
implant 5120 when the dilator 5124 reaches the cap element 51. The
cap element 5122 is preferably configured to be harder in texture
than the surrounding peri-implant fibrous tissue, allowing the
cannula 5124 to be guided over the implant body 5120 without
cutting the softer material of the implant body. Next, the implant
5120 and recapture assembly 5124 is removed.
Delivery Systems
[0077] The various embodiments disclosed in Conrad as well as the
embodiments of the present invention disclosed herein may be
deployed within a delivery system, such as the delivery system
disclosed in the Frazier '519 publication (e.g., the delivery
system illustrated in FIGS. 62A-D of the Frazier '519 publication).
In one embodiment, as illustrated in FIGS. 62B-C of the Frazier
'519 publication, a delivery tool comprises a pushrod attached to
an actuator handle, the pushrod having a distal position and a
proximal position which can be manipulated by a user through the
actuator handle. An implant comprising a tissue ingrowth end,
static end, and an elongated member, therebetween, such as, for
example, an implant illustrated in FIGS. 1-4 of Conrad, may be
loaded into the delivery tool by attaching the end(s) of the
elongated member to an attachment site on a spool within the
delivery tool. When the elongated member is attached to the spool
and the dial attached to the spool is rotated, the elongated
member, including the tissue ingrowth end, are pulled into the
tubular body as the elongated member is wound around the spool. The
proximal pulling of the tissue ingrowth end into the delivery tube
causes the tissue ingrowth end to retract into a relatively compact
delivery profile configuration and into the tubular body. When the
actuator handle is moved from the loading position to the deployed
position, the actuator handle overcomes the bias of the resistance
structure to release the rotation resistance. This allows the spool
to freely rotate and to quickly deploy the tissue ingrowth end,
followed by the rest of the elongated member, into the tissue. The
speed with which the tissue ingrowth end is deployed may affect the
degree of tissue engagement by the tissue ingrowth end. In some
instances, it is desirable to reduce rotation resistance in the
delivery phase compared to the loading phase of the delivery tool
usage.
[0078] While this invention has been particularly shown and
described with references to embodiments thereof, it will be
understood by those skilled in the art that various changes in form
and details may be made therein without departing from the scope of
the invention. For example, in some embodiments, a tongue or soft
palate implant may have one or more elements of different
embodiments described herein, for example, one or more anchors
disclosed in the Frazier '519 publication, '058 provisional
application, or Jackson '652 application and one or more adjustment
elements described in the Frazier '519 publication, '230
provisional application, or the Dineen '642 application.
Furthermore, the invention encompasses other combinations of any or
all of the disclosures of the aforementioned references. For all of
the embodiments described above, the steps of the methods need not
be performed sequentially.
* * * * *